The US$11 Bn market for patient blood management (PBM) is poised for a healthy growth outlook. A new research study in progress at Fairfield Market Research suggests that the demand for proper patient blood management will grow strong with critically rising need for blood resource conservation amid the rapidly evolving blood transfusion space, and disease treatment delivery. As blood transfusion remains the backbone of the in-patient care in world of medicine and healthcare, the need for ensuring blood availability whenever required along with effective disease treatment.

Get Sample Copy of Patient Blood Management Market: https://www.fairfieldmarketresearch.com/report/patient-blood-management-market/request-sample

Growing Inclination toward Blood Resource Preservation Bodes Well for PBM Market

Decreasing rate of post-operative morbidity remains among the strongest factors contributing toward the growth of market. The quality of life of patients suffering chronic health conditions has also been improved a lot when compared with the situation earlier, roughly a decade ago. This also will play out as a favourable growth factor for patient blood management market. In addition, decreased donor exposure to a variety of infections, and remarkably falling rate of mortality associated with certain diseases accompanying high surgical risk further elevate the growth prospects of patient blood management.
Given the advantages like these and more, there has been a growing inclination of several nations toward preserving their blood resources. While this would potentially be a means of eliminating the autologous transfusions wherever possible to eventually bring down the overall costs associated. This would thus create a situation where a lesser number of donors would be required each year. With specific guidelines by their side, more physicians are thus likely to register demand for efficient patient blood management.

PBM to Gain Traction in an Effort to Address Global Anaemia Burden

Concerns around anaemia continue to aggravate worldwide, which also point to poor outcomes for several other conditions, including kidney disorders, heart failure, stroke, cancers, chronic obstructive pulmonary disease (COPD), and autoimmune disorders. Patient blood management is being looked at as a potentially viable, and effective way to avoid unnecessary blood transfusions, and promote optimum haemoglobin care, especially targeting chronic disease patients. There has been a surge in demand for PBM over the recent past as facilities aim to minimise intraoperative blood transfusion, reduce the perioperative blood loss, and optimise postoperative IV fluid management. This is likely to remain the prime booster to market expansion.

The Growing Role of Blood Banks

Blood banks are expected to retain the top spot as an end user of PBM techniques, primarily used for platelets, followed by red blood cells. As platelets have a short shelf-life and require to be transfused within the span of five days after collection, blood banks continue to generate demand for effective, and efficient patient blood management techniques for proper storage, and transfer to hospitals for transfusion. This entire process serves a critical role in preserving platelets in their original form, thereby avoiding any potential complications that might appear during or post-transfusion. Blood banks will this remain a significant factor driving the developments in patient blood management market.

For More Information of Patient Blood Management Market Visit: https://www.fairfieldmarketresearch.com/report/patient-blood-management-market


North America to continue leading the global market

Receiving notable support from governments, academic research organisations, universities, private companies, as well as hospitals and other healthcare facilities, the PBM landscape has been building up strong presence across the North American region. The blood transfusion market here is highly active, which is likely to receive a push from growing public awareness regarding safe transfusion practices, surging need for blood transfusion, and deepening technology penetration. Ascending demand for platelets, cord blood stem cells, and artificial blood substitutes is also projected to uplift the growth outlook of PBM market in North America. A number of clinics, and hospitals are increasingly showcasing interest in adopting patient blood management tools for safer transfusion practices under their respective blood banks.


About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

Contact

Fairfield Market Research
London, UK
UK +44 (0)20 30025888   
USA (Toll-free) +1 (844) 3829746 
Web: https://www.fairfieldmarketresearch.com/
Email: [email protected]
Follow Us: LinkedIn